Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'LEGHA SS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Verschraegen, CF; Benjapibal, M; Supakarapongkul, W; Levy, LB; Ross, M; Atkinson, EN; Bodurka-Bevers, D; Kavanagh, JJ; Kudelka, AP; Legha, SS
      Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    2. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    3. Ellerhorst, JA; Bedikian, A; Ring, S; Buzaid, AC; Eton, O; Legha, SS
      Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

      ONCOLOGY REPORTS
    4. Woll, E; Bedikian, A; Legha, SS
      Uveal melanoma: natural history and treatment options for metastatic disease

      MELANOMA RESEARCH
    5. Bedikian, AY; Legha, SS; Eton, O; Buzaid, AC; Papadopoulos, N; Plager, C; McIntyre, S; Viallet, J
      Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma

      ANTI-CANCER DRUGS
    6. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    7. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    8. PRIDE MW; SHUEY S; GRILLOLOPEZ A; BRASLAWSKY O; ROSS M; LEGHA SS; ETON O; BUZAID A; IOANNIDES C; MURRAY JL
      ENHANCEMENT OF CELL-MEDIATED-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES (MELIMMUNE(R)) THAT MIMIC THE HIGH-MOLECULAR-WEIGHT PROTEOGLYCAN ANTIGEN

      Clinical cancer research
    9. BUZAID AC; ALIOSMAN F; AKANDE N; GRIMM EA; LEE JJ; BEDIKIAN A; ETON O; PAPADOPOULOS N; PLAGER C; LEGHA SS; BENJAMIN RS
      DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA

      Melanoma research
    10. ANDERSON CM; BUZAID AC; SUSSMAN J; LEE JJ; ALIOSMAN F; BRAUNSCHWEIGER PG; PLAGER C; BEDIKIAN A; PAPADOPOULOS N; ETON O; LEGHA SS; GRIMM EA
      NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY

      Melanoma research
    11. Buzaid, AC; Colome, M; Bedikian, A; Eton, O; Legha, SS; Papadopoulos, N; Plager, C; Ross, M; Lee, JE; Mansfield, P; Rice, J; Ring, S; Lee, JJ; Strom, E; Benjamin, R
      Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

      MELANOMA RESEARCH
    12. KEILHOLZ U; CONRADT C; LEGHA SS; KHAYAT D; SCHEIBENBOGEN C; THATCHER N; GOEY SH; GORE M; DORVAL T; HANCOCK B; PUNT CJA; DUMMER R; AVRIL MF; BROCKER EB; BENHAMMOUDA A; EGGERMONT AMM; PRITSCH M
      RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS

      Journal of clinical oncology
    13. LEGHA SS; RING S; ETON O; BEDIKIAN A; BUZAID AC; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA

      Journal of clinical oncology
    14. ETON O; LEGHA SS; MOON TE; BUZAID AC; PAPADOPOULOS NE; PLAGER C; BURGESS AM; BEDIKIAN AY; RING S; DONG Q; GLASSMAN AB; BALCH CM; BENJAMIN RS
      PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA

      Journal of clinical oncology
    15. LEGHA SS; RING S; ETON O; BEDIKIAN A; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE

      The cancer journal from Scientific American
    16. BEDIKIAN AY; LEGHA SS; ETON O; BUZAID AC; PAPADOPOULOS N; COATES S; SIMMONS T; NEEFE J; VONROEMELING R
      PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA

      Annals of oncology
    17. BUZAID AC; ROSS MI; BALCH CM; SOONG SJ; MCCARTHY WH; TINOCO L; MANSFIELD P; LEE JE; BEDIKIAN A; ETON O; PLAGER C; PAPADOPOULOS N; LEGHA SS; BENJAMIN RS
      CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM

      Journal of clinical oncology
    18. KIRKWOOD JM; LEGHA SS
      ADVANCES IN THE DIAGNOSIS AND TREATMENT OF MALIGNANT-MELANOMA - INTRODUCTION

      Seminars in oncology
    19. LEGHA SS
      THE ROLE OF INTERFERON-ALFA IN THE TREATMENT OF METASTATIC MELANOMA

      Seminars in oncology
    20. LEGHA SS
      DURABLE COMPLETE RESPONSES IN METASTATIC MELANOMA TREATED WITH INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFA AND CHEMOTHERAPY

      Seminars in oncology
    21. LEGHA SS; RING S; BEDIKIAN A; PLAGER C; ETON O; BUZAID AC; PAPADOPOULOS N
      TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA

      Annals of oncology
    22. SMITH TL; LEE JJ; KANTARJIAN HM; LEGHA SS; RABER MN
      DESIGN AND RESULTS OF PHASE-I CANCER CLINICAL-TRIALS - 3-YEAR EXPERIENCE AT MD-ANDERSON-CANCER-CENTER

      Journal of clinical oncology
    23. LEGHA SS; GIANAN MA; PLAGER C; ETON OE; PAPADOPOULOUS NEJ
      EVALUATION OF INTERLEUKIN-2 ADMINISTERED BY CONTINUOUS-INFUSION IN PATIENTS WITH METASTATIC MELANOMA

      Cancer
    24. BUZAID AC; TINOCO LA; JENDIROBA D; TU ZN; LEE JJ; LEGHA SS; ROSS MI; BALCH CM; BENJAMIN RS
      PROGNOSTIC VALUE OF SIZE OF LYMPH-NODE METASTASES IN PATIENTS WITH CUTANEOUS MELANOMA

      Journal of clinical oncology
    25. BUZAID AC; TINOCO L; ROSS MI; LEGHA SS; BENJAMIN RS
      ROLE OF COMPUTED-TOMOGRAPHY IN THE STAGING OF PATIENTS WITH LOCAL-REGIONAL METASTASES OF MELANOMA

      Journal of clinical oncology
    26. BEDIKIAN AY; WEISS GR; LEGHA SS; BURRIS HA; ECKARDT JR; JENKINS J; ETON O; BUZAID AC; SMETZER L; VONHOFF DD; BENJAMIN RS
      PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY

      Journal of clinical oncology
    27. LEGHA SS
      IDIOPATHIC DILATED CARDIOMYOPATHY

      The New England journal of medicine
    28. BEDIKIAN AY; LEGHA SS; MAVLIGIT G; CARRASCO CH; KHORANA S; PLAGER C; PAPADOPOULOS N; BENJAMIN RS
      TREATMENT OF UVEAL MELANOMA METASTATIC TO THE LIVER - A REVIEW OF THEM-D-ANDERSON-CANCER-CENTER EXPERIENCE AND PROGNOSTIC FACTORS

      Cancer
    29. ANDERLINI P; BUZAID AC; LEGHA SS
      ACUTE RHABDOMYOLYSIS AFTER CONCURRENT ADMINISTRATION OF INTERLEUKIN-2, INTERFERON-ALFA, AND CHEMOTHERAPY FOR METASTATIC MELANOMA

      Cancer
    30. LEGHA SS
      TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2

      Journal of the National Cancer Institute
    31. BUZAID AC; GRIMM EA; ALIOSMAN F; RING S; ETON O; PAPADOPOULOS NE; BEDIKIAN A; PLAGER C; LEGHA SS; BENJAMIN R
      MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS

      Melanoma research
    32. MURRAY JL; CUNNINGHAM JE; BREWER H; MUJOO K; ZUKIWSKI AA; PODOLOFF DA; KASI LP; BHADKAMKAR V; FRITSCHE HA; BENJAMIN RS; LEGHA SS; ATER JL; JAFFE N; ITOH K; ROSS MI; BUCANA CD; THOMPSON L; CHEUNG L; ROSENBLUM MG
      PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS

      Journal of clinical oncology
    33. BUZAID AC; LEGHA SS
      COMBINATION OF CHEMOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA FOR THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology
    34. BUZAID AC; LEGHA SS; BALCH CM; ROSS M; RING S; PLAGER C; PAPADOPOULOS NE; ELNAGGAR AK; BENJAMIN RS
      PILOT-STUDY OF PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE,AND DACARBAZINE IN PATIENTS WITH LOCAL-REGIONAL RECURRENCE OF MELANOMA

      Cancer
    35. BUZAID AC; LEGHA SS; BALCH CM; ROSS M; RING S; PLAGER C; PAPADOPOULOS NE; ELNAGGAR AK; BENJAMIN RS
      PILOT-STUDY OF PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE,AND DACARBAZINE IN PATIENTS WITH LOCAL-REGIONAL RECURRENCE OF MELANOMA

      Cancer
    36. KOLLER CA; GORSKI CC; BENJAMIN RS; LEGHA SS; PAPADOPOULOS NE; PLAGER C
      A PHASE-I TRIAL OF WEEKLY LOMUSTINE IN PATIENTS WITH ADVANCED CANCER

      Cancer
    37. LEGHA SS
      ARE PROTECTED ENVIRONMENTS NECESSARY FOR RECIPIENTS OF BONE-MARROW TRANSPLANTS

      Annals of internal medicine
    38. DHINGRA K; PAPADOPOULOS N; LIPPMAN S; LOTAN R; LEGHA SS
      PHASE-II STUDY OF ALPHA-INTERFERON AND 13-CIS-RETINOIC ACID IN METASTATIC MELANOMA

      Investigational new drugs
    39. LEGHA SS; BUZAID AC
      ROLE OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFAAND CHEMOTHERAPY IN THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology
    40. BURGESS MA; LEGHA SS
      MITOTANE FAILURE IN ADRENOCORTICAL CANCER - WHERE NEXT

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 02:30:49